Announcements Trials
Browse Landscape

Phase

Phase 2 7Phase 1 6Phase 1/2 2Phase NA 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Pancreatic Neoplasms 18Carcinoma, Non-Small-Cell Lung 5Urinary Bladder Neoplasms 3Nasopharyngeal Carcinoma 3Recurrence 2Non-Muscle Invasive Bladder Neoplasms 2Lung Neoplasms 2Carcinoma, Hepatocellular 2Biliary Tract Neoplasms 2Uterine Neoplasms 1Thromboembolism 1Stomach Neoplasms 1Ovarian Neoplasms 1Osteosarcoma 1Neoplasm Metastasis 1Nasopharyngeal Neoplasms 1NSCLC 1Malnutrition 1Lymphoma, T-Cell, Peripheral 1Lymphoma, T-Cell 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Extranodal NK-T-Cell 1Locally Advanced Pancreatic Cancer 1Infiltrating Bladder Urothelial Carcinoma 1Immunoblastic Lymphadenopathy 1Hypoxia 1Gallbladder Neoplasms 1Cholangiocarcinoma 1

Interventions

Methotrexate 3Ifosfamide 3Cisplatin 3Magnetic Resonance Spectroscopy 2Leucovorin 2Electroacupuncture 2Doxorubicin 2sargramostim 1regorafenib 1delta 24-sterol reductase 1apatinib 1Tissue and Organ Procurement 1Surveys and Questionnaires 1Surgical Procedures, Operative 1Standard of Care 1Resistance Training 1Radiotherapy, Image-Guided 1Proton Therapy 1Positron Emission Tomography Computed Tomography 1Physical Therapy Modalities 1Pentetic Acid 1Palliative Care 1Nutritional Support 1Neuropsychological Tests 1Neoadjuvant Therapy 1Minocycline 1Mesna 1Heparin 1Granulocyte-Macrophage Colony-Stimulating Factor 1Glutamine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Osteosarcoma × Gemcitabine × Clear all
NCT00673179 2014-09-10

Doxorubicin With Cisplatin, High-Dose Methotrexate, and Additional Risk-Adapted Outpatient Chemotherapy

M.D. Anderson Cancer Center

Phase NA Terminated
7 enrolled 3 charts
Sarcoma

Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡